JAZZ News and Press, Jazz Pharmaceuticals plc From 11/14/23

Total Deal Value of Up to $770.5 million including Upfront Payment and Potential Milestone Payments Autifony Eligible to Receive Royalties on Future Net Sales Autifony Therapeutics Limited (“Autifony”), which is pioneering the development of novel pharmaceutical ...

2023-11-08 23:34:12 ET Call Start: 16:30 Call End: 17:52 Jazz Pharmaceuticals PLC (JAZZ) Q3 2023 Earnings Conference Call November 08, 2023, 16:30 ET Company Participants Robert Iannone - EVP & Global Head, Research & Development Kim Sablich - EVP &am...

2023-11-08 23:34:12 ET Fleetcor Technologies, Inc. (FLT) Q3 2023 Earnings Conference Call November 08, 2023, 17:30 ET Company Participants James Eglseder - Head, IR Ronald Clarke - Chairman, President & CEO Thomas Panther - CFO Conference Call Participa...

2023-11-08 16:12:15 ET More on Jazz Pharmaceuticals Jazz Pharma: Playing The High Notes With Xywav Jazz Pharmaceuticals Q3 2023 Earnings Preview Jazz Pharmaceuticals Q3 2023 Earnings Preview Seeking Alpha’s Quant Rating on Jazz Pharmaceuticals ...

Jazz Pharmaceuticals Announces Third Quarter 2023 Financial Results and Updates Financial Guidance PR Newswire – 3Q23 total revenues of $972 million – – Combined revenues from key growth drivers, Xywav ® , Epidiolex ® and Rylaze &#x...

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

Jazz Pharmaceuticals plc (JAZZ) is expected to report $4.21 for Q3 2023

Jazz Pharmaceuticals and MD Anderson Announce Five-Year Collaboration to Evaluate Zanidatamab in HER2-Expressing Cancers PR Newswire DUBLIN and HOUSTON , Nov. 7, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and The University of ...

Jazz Pharmaceuticals to Report 2023 Third Quarter Financial Results on November 8, 2023 PR Newswire DUBLIN , Oct. 25, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2023 third quarter financial results on We...

2023-10-25 08:30:32 ET Palm Beach, FL – October 25, 2023 – FinancialNewsMedia.com News Commentary – The R&D for cancer vaccines has been growing in the last few years and is projected to continue through the next decade. A cancer vaccine is used to eithe...